Raymed Labs Ltd has informed BSE that a meeting of Board of Directors of the Company will be held on February 05, 2015, inter alia, to consider and take on record:
1. To Consider the Unaudited Financial Result and Limited Review Report for the quarter ended December 31, 2014.
2. To Consider and approve the Capital Reduction pursuant to the provisions of section 66 and all other applicable provisions of the Companies Act, 2013 subject to approval of the members.
3. To consider the Resignation of Mr. Ankur Arora from the directorship of the Company.
Further, pursuant to the code of conduct for prevention of insider trading of the Company, the trading window for all designated employees and directors will be closed from January 29, 2015 to February 05, 2015 (both days inclusive) and shall remain closed till 24 hours after results are made public on February 05, 2015.